I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Fenaux, Pierre
789
results:
english X
Search for persons
X
Format
Online (789)
Mediatypes
E-Books (1)
Articles (Online) (335)
Bookchapter (Online) (2)
OpenAccess-fulltext (451)
Sorted by: Relevance
Sorted by: Year
?
1
Sabatolimab plus hypomethylating agents in previously untre..:
Zeidan, Amer M
;
Ando, Kiyoshi
;
Rauzy, Odile
...
The Lancet Haematology. 11 (2024) 1 - p. e38-e50 , 2024
Link:
https://doi.org/10.1016/..
?
2
Clinical impact of genetic alterations including germline D..:
Sébert, Marie
;
Freiman, Lucie
;
Chaffaut, Cendrine
...
Leukemia. 38 (2024) 4 - p. 918-922 , 2024
Link:
https://doi.org/10.1038/..
?
3
Niclosamide combined to Azacitidine to target TP53-mutated ..:
Maslah, Nabih
;
Rety, Salome
;
Bonnamy, Melina
...
Leukemia. , 2024
Link:
https://doi.org/10.1038/..
?
4
Molecular alterations monitoring in myelodysplastic patient..:
Robin, Marie
;
Nibourel, Olivier
;
Tournaire, Martin
...
Bone Marrow Transplantation. , 2024
Link:
https://doi.org/10.1038/..
?
5
Imetelstat in patients with lower-risk myelodysplastic synd..:
Platzbecker, Uwe
;
Santini, Valeria
;
Fenaux, Pierre
...
The Lancet. 403 (2024) 10423 - p. 249-260 , 2024
Link:
https://doi.org/10.1016/..
?
6
Kidney involvement in myelodysplastic syndromes:
Lafargue, Marie-Camille
;
Van Huyen, Jean-Paul Duong
;
Rennke, Helmut G
...
Clinical Kidney Journal. , 2024
Link:
https://doi.org/10.1093/..
?
7
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Ph..:
Konopleva, Marina Y.
;
Dail, Monique
;
Daver, Naval G.
...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 364-374 , 2024
Link:
https://doi.org/10.1016/..
?
8
Toward a more patient‐centered drug development process in ..:
Efficace, Fabio
;
Buckstein, Rena
;
Abel, Gregory A.
...
HemaSphere. 8 (2024) 5 - p. , 2024
Link:
https://doi.org/10.1002/..
?
9
Accelerated DNA replication fork speed due to loss of R-loo..:
Rombaut, David
;
Lefèvre, Carine
;
Rached, Tony
...
Nature Communications. 15 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
10
Cutaneous clonal mature plasmacytoid dendritic cell dermato..:
Mahévas, Thibault
;
Osio, Amélie
;
Larcher, Lise
...
Blood Advances. 8 (2024) 12 - p. 3293-3298 , 2024
Link:
https://doi.org/10.1182/..
?
11
Olutasidenib in post-venetoclax patients with mutant isocit..:
Cortes, Jorge
;
Jonas, Brian A.
;
Schiller, Gary
...
Leukemia & Lymphoma. , 2024
Link:
https://doi.org/10.1080/..
?
12
Germline CHEK2 mutations in patients with myeloid neoplasms:
Freiman, Lucie
;
Larcher, Lise
;
Tueur, Giulia
...
Leukemia. 38 (2024) 4 - p. 908-911 , 2024
Link:
https://doi.org/10.1038/..
?
13
Guadecitabine vs TC in relapsed/refractory AML after intens..:
Roboz, Gail J.
;
Sanz, Guillermo
;
Griffiths, Elizabeth A.
...
Blood Advances. 8 (2024) 8 - p. 2020-2029 , 2024
Link:
https://doi.org/10.1182/..
?
14
#2663 KIDNEY INVOLVEMENT IN MYELODYSPLASTIC SYNDROMES:
Lafargue, Marie-Camille
;
Van Huyen, Jean-Paul Duong
;
Isnard, Pierre
...
Nephrology Dialysis Transplantation. 38 (2023) Supplement_1 - p. , 2023
Link:
https://doi.org/10.1093/..
?
15
MDS-367 A Phase II/III Trial of Oral Azacitidine (Oral-AZA)..:
Garcia-Manero, Guillermo
;
Santini, Valeria
;
Fenaux, Pierre
...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S364 , 2023
Link:
https://doi.org/10.1016/..
1-15